Did Your Business Purchase Pharmaceutical Drugs? You May be Eligible to Recover Money!
Purchase dates: On or after January 1, 2010
Eligible Class Members
If certified, eligible Class Members include all dispensers of drugs (including hospitals and independent pharmacies, but excluding all pharmacies owned and operated by publicly traded companies and hospitals owned or operated by government entities), in the “Eligible Jurisdictions”, that, from January 1, 2010 to the present, purchased one or more of the “Drugs at Issue” from any source other than the manufacturer Defendants.
Eligible Jurisdictions:
AL, AZ, CA, CT, DE, FL, IA, KS, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NM, NY, NC, ND, OR, RI, SD, TN, UT, VT WV, WI and the District of Columbia.
No Filing Deadline at This Time
Get a copy of the case summary by entering the information below.
Defendants
The Defendants include:
The Defendants include: Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Actavis Elizabeth LLC; Amneal Pharmaceuticals, Inc.; Amneal Pharmaceuticals LLC; Ara Aprahamian; Aurobindo Pharma U.S.A., Inc.; Breckenridge Pharmaceutical, Inc. (“Breckenridge”); Mitchell Blashinsky; Douglas Boothe; Fougera Pharmaceuticals Inc.; Glenmark Pharmaceuticals, Inc.; James “Jim” Grauso; Greenstone LLC; G & W Laboratories; Walter Kaczmarek; Armando Kellum; Lupin Pharmaceuticals, Inc.; Mylan Inc.; Mylan Pharmaceuticals, Inc.; Mylan N.V.; Kurt Orlofski; Michael Perfetto; Perrigo New York, Inc.; Pfizer, Inc.; Sandoz, Inc.; Sun Pharmaceutical Industries, Inc.; Taro Pharmaceuticals U.S.A, Inc.; Erika Vogel-Baylor; John Wesolowski; and Wockhardt USA LLC.
Drugs at Issue:
Alclometasone dipropionate cream
Alclometasone dipropionate ointment
Adapalene cream
Ammonium lactate cream
Ammonium lactate lotion
Bromocriptine mesylate tabs
Carbamazepine oral suspension
Calcipotriene solution
Calcipotriene-Betamethasone dipropionate
ointment
Cefpodoxime proxetil oral suspension
Cefpodoxime proxetil tablets
Ciclopirox olamine cream
Ciclopirox shampoo
Ciclopirox solution
Clindamycin phosphate cream
Clindamycin phosphate gel
Clindamycin phosphate lotion
Clindamycin phosphate solution
Clotrimazole-Betamethasone dipropionate cream
Clotrimazole-Betamethasone dipropionate lotion
Clotrimazole cream
Cyproheptadine hydrochloride tablets
Desonide lotion
Desoximetasone ointment
Erythromycin base/ethyl alcohol solution
Estradiol
Ethambutol hydrochloride tablets
Fluocinolone acetonide cream
Fluocinolone acetonide ointment
Fluocinonide solution
Fluticasone propionate lotion
Griseofulvin microsize tablets
Halobetasol propionate cream
Halobetasol propionate ointment
Hydrocortisone acetate suppositories
Methazolamide tablets
Methylphenidate hydrochloride ER tablets
Methylphenidate hydrochloride IR tablets
Methylprednisolone tablets
Metronidazole .1% gel
Metronidazole .75% cream
Metronidazole .75% lotion
Mometasone furoate cream
Mometasone furoate ointment
Mometasone furoate solution
Nafcillin sodium injectable vials
Norethindrone acetate tablets
Oxacillin sodium injectable vials
Phenytoin sodium capsules
Prochlorperazine maleate suppositories
Promethazine hydrochloride suppositories
Propanolol hydrochloride extended release tablets
Tacrolimus ointment
Terconazole cream
Triamcinolone acetonide cream
Triamcinolone acetonide ointment
This is one of many class actions we are following. If you are interested in learning more about this case or the class action administration services in general, feel free to contact us of fill out the form above.
Case History
Numerous class action lawsuits were filed over the past several years alleging the Defendants conspired to allocate markets and artificially raise, fix, maintain and/or stabilize the price of the generic pharmaceutical drugs listed above in violation of federal antitrust laws. The class has now entered into a settlement with
Breckenridge in the amount of $1 million (this settlement is pending final approval). The litigation is ongoing against the remaining Defendants so it is possible that additional funds may become available to the class if additional settlements are reached in the future.
This is not an official Court Notice. Information contained in this Summary is subject to change. Class Counsel or the Settlement Administrator may be contacted for additional settlement information. You also may visit the Court-approved website, once it is available. Please understand that you have the right to file on your own. The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation.